Literature DB >> 11389791

Clinical implications of elevated lipoprotein(a).

A von Eckardstein1, G Assmann.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11389791     DOI： 10.1007/s11883-001-0017-8

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN： 1523-3804            Impact factor:   5.113


× No keyword cloud information.
  38 in total

1.  Evaluation of lipoprotein(a) and genetic prothrombotic risk factors in patients with recurrent foetal loss.

Authors:  U Nowak-Göttl; B Sonntag; R Junker; U Cirkel; A von Eckardstein
Journal:  Thromb Haemost       Date:  2000-02       Impact factor: 5.249

2.  Lipoprotein(a) as a risk predictor for cardiac mortality in patients with acute coronary syndromes.

Authors:  P Stubbs; M Seed; D Lane; P Collinson; F Kendall; M Noble
Journal:  Eur Heart J       Date:  1998-09       Impact factor: 29.983

3.  Elevated plasma lipoprotein (a)--a potential risk factor for thromboembolic complications in polycythaemia vera.

Authors:  K LeBlanc; J Samuelsson
Journal:  Eur J Haematol       Date:  1996-09       Impact factor: 2.997

4.  Use of a reference material proposed by the International Federation of Clinical Chemistry and Laboratory Medicine to evaluate analytical methods for the determination of plasma lipoprotein(a).

Authors:  S M Marcovina; J J Albers; A M Scanu; H Kennedy; F Giaculli; K Berg; R Couderc; F Dati; N Rifai; I Sakurabayashi; J R Tate; A Steinmetz
Journal:  Clin Chem       Date:  2000-12       Impact factor: 8.327

5.  Increased lipoprotein(a) is an important risk factor for venous thromboembolism in childhood.

Authors:  U Nowak-Göttl; R Junker; M Hartmeier; H G Koch; N Münchow; G Assmann; A von Eckardstein
Journal:  Circulation       Date:  1999-08-17       Impact factor: 29.690

Review 6.  The seventh myth of lipoprotein(a): where and how is it assembled?

Authors:  H Dieplinger; G Utermann
Journal:  Curr Opin Lipidol       Date:  1999-06       Impact factor: 4.776

Review 7.  Genetic architecture and evolution of the lipoprotein(a) trait.

Authors:  G Utermann
Journal:  Curr Opin Lipidol       Date:  1999-04       Impact factor: 4.776

8.  Is lipoprotein(a) an independent risk factor for ischemic heart disease in men? The Quebec Cardiovascular Study.

Authors:  B Cantin; F Gagnon; S Moorjani; J P Després; B Lamarche; P J Lupien; G R Dagenais
Journal:  J Am Coll Cardiol       Date:  1998-03-01       Impact factor: 24.094

9.  Plasma Lp(a) levels are increased in patients with chronic thromboembolic pulmonary hypertension.

Authors:  M Ignatescu; K Kostner; G Zorn; M Kneussl; G Maurer; I M Lang; K Huber
Journal:  Thromb Haemost       Date:  1998-08       Impact factor: 5.249

10.  Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants.

Authors:  M Jauhiainen; P Koskinen; C Ehnholm; M H Frick; M Mänttäri; V Manninen; J K Huttunen
Journal:  Atherosclerosis       Date:  1991-07       Impact factor: 5.162
View more
  1 in total

Review 1.  Lipoprotein(a) and the atherothrombotic process: mechanistic insights and clinical implications.

Authors:  Angelo M Scanu
Journal:  Curr Atheroscler Rep       Date:  2003-03       Impact factor: 5.113
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.